Application Of A Machine Learning-Driven, Multibiomarker Panel For Prediction Of Incident Cardiovascular Events In Patients With Suspected Myocardial Infarction
BIOMARKERS IN MEDICINE(2020)
摘要
Background: In patients with suspected myocardial infarction (MI), we sought to validate a machine learning-driven, multibiomarker panel for prediction of incident major adverse cardiovascular events (MACE). Methodology & results: A previously described prognostic panel for MACE consisting of four biomarkers was measured in 748 patients with suspected MI. The investigated end point was incident MACE within 1 year. The prognostic value of a continuous score and an optimal cut-off was investigated. The area under the curve was 0.86 for the overall model. Using the optimal cut-off resulted in a negative predictive value of 99.4% for incident MACE. Patients with an elevated prognostic score were at high risk for MACE. Conclusion: Among patients with suspected MI, we validated a multibiomarker panel for predicting 1-year MACE. Clinical Trial Registration: NCT02355457 (ClinicalTrials.gov)Graphical abstract
更多查看译文
关键词
ACS, artificial intelligence, biomarkers, machine learning, major adverse cardiac events, myocardial infarction, noninvasive risk assessment, outcome, prediction
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要